Cargando…
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
BACKGROUND: Faecal calprotectin (FC), a cytosolic protein released by neutrophils (S100 family) in response to inflammation, is a simple, non-invasive test that can be used to differentiate irritable bowel syndrome (IBS) with inflammatory bowel disease (IBD), where there can be considerable symptom...
Autores principales: | Dhaliwal, A, Zeino, Z, Tomkins, C, Cheung, M, Nwokolo, C, Smith, S, Harmston, C, Arasaradnam, R P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283700/ https://www.ncbi.nlm.nih.gov/pubmed/25580205 http://dx.doi.org/10.1136/flgastro-2013-100420 |
Ejemplares similares
-
What calprotectin cut-offs should apply for IBD in general practice?
por: Landis, Darryl, et al.
Publicado: (2016) -
Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
por: Farrugia, Alexia, et al.
Publicado: (2019) -
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016) -
A practical guide to thiopurine prescribing and monitoring in IBD
por: Warner, Ben, et al.
Publicado: (2018) -
An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020)